Share
Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Manage episode 498423047 series 2760008
Content provided by FEG Investment Advisors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by FEG Investment Advisors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
In this episode of FEG’s Insight Bridge Podcast, Greg Dowling speaks with Peter Kolchinsky, Managing Partner at RA Capital. Together they delve into the drivers and details of today’s biotech industry, how to foster innovation and why Peter is optimistic about biotech’s ability to address autoimmune disorders. Peter shares RA Capital’s investment approach, which emphasizes patience, rigor and selectiveness across healthcare and life science sectors.
You can find every episode of FEG Insight Bridge podcasts in one place and sign up to receive our other publications here.
Chapters
1. Podcast Introduction (00:00:00)
2. Introduction to RA Capital (00:01:17)
3. Inspiration for Biotech Investing (00:02:13)
4. Today's Biotech Opportunity (00:05:28)
5. Benefits of Active Management (00:07:53)
6. Defining the Biotech Investment Universe (00:09:23)
7. As a Sector Specialist, How Do You Look at Biotech Companies Differently? (00:10:35)
8. Big Pharma's Impact on Biotech M&A (00:14:05)
9. What is Tech Atlas? (00:19:14)
10. The Tech Atlas Process in Action (00:23:04)
11. How Federal Policy is Shaping Healthcare Regulation and Drug Approvals (00:26:36)
12. Outlook and Why RA Capital Remains Optimistic (00:30:55)
13. Biotech Book Recommendation and Peter's Fun Fact (00:34:41)
64 episodes
))
